Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Rural Health. 2012 May 31;29(1):106–112. doi: 10.1111/j.1748-0361.2012.00415.x

Table 2.

Full logistic models of baseline variables predicting self-engagement and cessation outcomes.

Use of cessation
medication 30–36
months
At least one 24-hr quit
attempt 30–36 months
7-day point prevalence quit
status at 36 months
Predictor variable Odds Ratio
(95% CI)
P Odds Ratio
(95% CI)
P Odds Ratio
(95% CI)
P
Treatment Arm
     Control (Referent)
     LDM 1.19
(0.67, 2.11)
.56 0.47
(0.25, 0.87)
.02 0.56
(0.15, 2.04)
.38
     HDM 1.03
(0.56, 1.88)
.93 0.68
(0.37, 1.25)
.21 0.48
(0.11, 1.98)
.31
Stage of Change
     Pre-contemplation (Referent)
     Contemplation 1.02
(0.52, 2.02)
0.95
     Preparation 2.39
(1.08, 5.29)
0.03
NRT use in 30–36 months
     No (Referent)
     Yes 4.86
(2.10, 11.26)
< 0.0005
Varenicline use in 30–36 months
     No (Referent)
     Yes 4.19
(1.94, 9.09)
< 0.0005 7.79
(2.55, 23.87)
< .0005
Number of Cigarettes per day at
24 months
0.93
(0.90, 0.96)
< 0.0001
Motivation to quit at 24 months 1.13
(1.00, 1.29)
.05 0.99
(0.87, 1.12)
0.86
Confidence to quit at 24 months
Number of pharmacotherapy-
assisted quit attempts 0–24
months
1.22
(1.00, 1.48)
.05 1.28
(1.03, 1.58)
0.02